Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New coaching program helps seniors decide on dialysis with confidence

NCT ID NCT04392440

First seen Apr 03, 2026 · Last updated Jun 23, 2026 · Updated 14 times

Summary

This study tested a program called DIAL-SDM that trains kidney doctors and coaches older patients (65+) with advanced kidney disease to have better conversations about dialysis. The goal was to see if the program was practical and acceptable. 102 patients, their caregivers, and 20 doctors took part. The results showed the program was feasible and well-liked, but this was a small pilot study, so more research is needed to know if it actually improves decisions or health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Rochester

    Rochester, New York, 14642, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

communication training and coaching program

What this could lead to

If this approach works, it could help older kidney patients make more informed, values-aligned decisions about dialysis, potentially improving quality of life and reducing regret.

What could go wrong

This is a small pilot study focused on feasibility, not on health outcomes. The intervention may not change actual dialysis decisions or improve survival, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.